Learn more about the importance of good economic governance
Prioritising for HIV Investment
Prof Alan Whiteside of UKZN’s Health Economics and AIDS Research Division
Renowned health economist Alan Whiteside delivered a public lecture entitled “Economics and HIV: Costs and Consequences” at the University of KwaZulu-Natal in Durban on 12 October 2011. After reflecting on the past 30 years of HIV and AIDS science, politics and socio-economic challenges in South Africa, he cited projections reported last year in the AIDS2031 project conducted by CEGAA and the Results for Development Institute.
The AIDS2031 data illustrate the severity of South Africa’s continuing epidemic, the prospect of increased numbers on treatment, and the anticipated demands on the national fiscus and health services inherent in this scenario. While defending the biomedical evidence and moral imperative that form the basis for life-long ARV provision, Whiteside argued for equally heightened attention to prevention behaviour, so as to reduce the macro-economic impact of supporting three million people on HIV treatment.
CEGAA Director on CNBC Africa
The economic aspects of African HIV/AIDS responses
CEGAA Trustee and Founding Director, Teresa Guthrie, gave a live interview from Nairobi, Kenya, on ABN/CNBC Africa's "Beyond Markets" programme for World AIDS Day 2011. Replying to issues raised by presenter Lerato Mbele, Teresa described the positive impacts achieved in scaled-up responses to the pandemic, as well as projections and priorities for ongoing investment to counter the effects of the prevailing AIDS funding crisis.
We have produced a range of resources, including research and analysis reports, country assessments, training materials and tools, and Budget Briefs. For a selection of these, go to our Products page.
Other Related Resources:
Through our project research, communications within our network, and media scanning, CEGAA regularly sources useful material and details of related organisations. For access to these, go to the Policy Documents page, the Useful Links page and our Media Dossiers.